Company news
U.s. Stem Cell, Inc. (OTC:USRM) news
U.s. Stem Cell, Inc. news releases on 6ix. Latest, Sep 13, 2017: U.S. Stem Cell, Inc. Reports Debt Restructuring Agreement and Debt Reduction in Form 8-K
Press releases — page 2
U.S. Stem Cell, Inc. Reports Debt Restructuring Agreement and Debt Reduction in Form 8-K
September 12, 2017
U.S. Stem Cell, Inc. Corporate Office, Lab, and Clinic Remain Operational Post Hurricane Irma
September 11, 2017
Kristin Comella, U.S. Stem Cell's CSO, Named to the List of Top 50 Functional and Integrative Medical Doctors By DrAxe.Com
August 22, 2017
Kristin Comella, U.S. Stem Cell’s CSO, Co-Authors Scientific Paper on Irradiation-Induced Gland Damage Published in the International Medical Case Reports Journal
August 16, 2017
U.S. Stem Cell, Inc. Reports Most Successful Financial Performance in the Company's History
August 8, 2017
U.S. Stem Cell, Inc. Reports Continued Positive Results for Q2 2017
August 8, 2017
Kristin Comella, U.S. Stem Cell's CSO, Co-Authors Scientific Paper on Chronic Obstructive Pulmonary Disease (COPD) Published in the Journal of Clinical Medicine Research
July 12, 2017
NBA Star John Salley Partners with Stem Cell Centers of Excellence
June 28, 2017
Kristin Comella, U.S. Stem Cell's CSO, Co-Authors Scientific Paper on Intra-Articular Injection for Osteoarthritis Published in The Journal of Translational Medicine
June 20, 2017
U.S. Stem Cell to Focus on and Expand In-Clinic Therapies
June 18, 2017
Kristin Comella, U.S. Stem Cell's CSO, Co-Authored Paper Recognized as One of the Most Influential Scientific Papers of 2016 in the Journal of Translational Medicine
June 11, 2017
OTC Markets Group Welcomes Newly Verified OTCQB Companies – Dec. 30
December 30, 2014